# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Oct 16, 2023

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2023-10-16
- Accepted by EDGAR: Oct 16, 2023, 21:26 ET
- Period: 2023-10-12
- Accession: 0001104659-23-109423
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000110465923109423/tm2328531d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000110465923109423/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000110465923109423/tm2328531d1_8k.htm

Filed Oct 16, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-109423. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.